<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04646629</url>
  </required_header>
  <id_info>
    <org_study_id>NKYY_YXKT_IRB_2020_071_01</org_study_id>
    <nct_id>NCT04646629</nct_id>
  </id_info>
  <brief_title>Effect of Electroacupuncture on Sepsis-induced Intestinal Dysfunction</brief_title>
  <official_title>Effect of Electroacupuncture on Sepsis-induced Intestinal Dysfunction: a Prospective, Double-blind, Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jianbo Yu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tianjin Nankai Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Title: Effect of electroacupuncture on sepsis-induced intestinal dysfunction&#xD;
&#xD;
        2. Research center: single center&#xD;
&#xD;
        3. The Design of the study: Randomized, double-blind, controlled study&#xD;
&#xD;
        4. The population of the study: The patients over 18 years that met the criteria of&#xD;
           sepsis3.0 and with AGI grade II or above are enrolled in the study&#xD;
&#xD;
        5. Sample size: Enroll 60 patients (30patients in each group)&#xD;
&#xD;
        6. Interventions: Participants in the treatment group underwent 60 minutes acupuncture&#xD;
           (0.30mm×70mm) at ST36 (Zusanli) and ST37 (Shangjuxu) twice a day for seven days.&#xD;
           After&quot;Deqi&quot;,electroacupuncture stimulation apparatus (HANS G6805-2, Huayi Co, Shanghai,&#xD;
           China) is connected and maintained the end of treatment.&#xD;
&#xD;
           Participants in the control group received shallow needling (0.30mm×25mm) at ST36 and&#xD;
           ST37(nonacupoints located 1 inch beside acupoints, about 20mm). Specifically, the depth&#xD;
           of needle insertion into nonacupoints is 3-5mm and avoided manual stimulation and no&#xD;
           &quot;Deqi&quot; without actual current output.&#xD;
&#xD;
        7. The aim of the research: To investigate the effect of electroacupuncture on&#xD;
           sepsis-induced intestinal dysfunction.&#xD;
&#xD;
        8. Outcome# 1) Primary outcome: The intestinal function indicators including: 1) Clinical&#xD;
           symptoms: bowel sounds, intra-abdominal pressure, time to first exhaust/defecation,&#xD;
           daily tolerable enteral nutrition 2) Intestinal motility indicators: the levels of serum&#xD;
           motilin and gastrin 3) Intestinal barrier indicators: the levels of serum diamine&#xD;
           oxidase (DAO), D-lactic acid and I-FABP 2)Secondary outcome# Duration of mechanical&#xD;
           ventilation in patients with endotracheal intubation on ICU admission; Length of stay in&#xD;
           ICU and Length of stay in hospital; 30-day life quality and cognitive function after&#xD;
           surgery; All-cause 28-day mortality.&#xD;
&#xD;
        9. The estimated duration of the study#1-2years.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a randomized, double-blinded, placebo controlled and long-term follow-up&#xD;
      design. In this study, ST36 (Zusanli) and ST37 (Shangjuxu) were selected for&#xD;
      electroacupuncture treatment, accompanied with evaluating the effects on intestinal function&#xD;
      in septic patients. Meanwhile, the blood biochemical indexes such as heme oxygenase-1(HO-1),&#xD;
      PTEN induced putative kinase 1(PINK1), polo-like kinase 1(PLK1) and interleukin-6 are&#xD;
      detected. To clarify the effect of electroacupuncture on sepsis-induced intestinal&#xD;
      dysfunction is of great significance to the clinical applications and popularization of&#xD;
      traditional acupuncture treatment across the world.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 23, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The effect on intestinal motility</measure>
    <time_frame>an average of one year</time_frame>
    <description>Record the serum levels of motilin of the two groups</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The effect on intestinal motility</measure>
    <time_frame>an average of 1 year</time_frame>
    <description>Record the serum levels of gastrin of the two groups</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The effect on intestinal barrier</measure>
    <time_frame>up to 1 year</time_frame>
    <description>Record serum levels of DAO of the two groups</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The effect on intestinal barrier</measure>
    <time_frame>up to 12 months</time_frame>
    <description>Record serum levels of I-FABP of the two groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation in patients with endotracheal intubation in ICU</measure>
    <time_frame>one year</time_frame>
    <description>Duration of mechanical ventilation and endotracheal intubation in ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in hospital</measure>
    <time_frame>up to one year</time_frame>
    <description>ICU stay time and hospitalization time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause 28-day mortality</measure>
    <time_frame>12 months</time_frame>
    <description>All reasons (such as infection, hemorrhage) caused the mortality during the first 28 days</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Sepsis</condition>
  <condition>Intestinal Dysfunction</condition>
  <arm_group>
    <arm_group_label>electroacupuncture treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in the treatment group underwent 60 minutes acupuncture (0.30mm×70mm) at ST36 (Zusanli) and ST37 (Shangjuxu) twice a day for seven days. After&quot;Deqi&quot;,electroacupuncture stimulation apparatus (HANS G6805-2, Huayi Co, Shanghai, China) isconnected and maintained the end of treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham electroacupuncture treatment</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>sham electroacupuncture treatment participants in the control group received shallow needling (0.30mm×25mm) at ST36 and ST37(nonacupoints located 1 inch beside acupoints, about 20mm). Specifically, the depth of needle insertion into nonacupoints is 3-5mm and avoided manual stimulation and no &quot;Deqi&quot; without actual current output.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>electroacupuncture treatment</intervention_name>
    <description>Participants in the treatment group underwent 60 minutes acupuncture (0.30mm×70mm) at ST36 (Zusanli) and ST37 (Shangjuxu) twice a day for seven days.After &quot;Deqi&quot;, electroacupuncture stimulation apparatus (HANS G6805-2, Huayi Co, Shanghai, China) is connected with the density wave (2/100 Hz), width 0.25 ms, intensity of 1 ~ 30 mA (gradually increase to the patient's maximum tolerance) and maintained the end of treatment.</description>
    <arm_group_label>electroacupuncture treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham electroacupuncture treatment</intervention_name>
    <description>Participants in the sham electroacupuncture group received shallow needling (0.30mm×25mm) at ST36 and ST37(nonacupoints located 1 inch beside acupoints, about20mm). Specifically, the depth of needle insertion into nonacupoints is 3-5mm and avoided manual stimulation and no &quot;Deqi&quot; without actual current output, and retained the needle for the same time as treatment group</description>
    <arm_group_label>sham electroacupuncture treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Meet the diagnostic criteria of sepsis 3.0&#xD;
&#xD;
          2. AGI grade II or above,&#xD;
&#xD;
          3. At least 18 years old&#xD;
&#xD;
          4. Volunteer to participate in this study and sign the informed consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with bowel dysfunction caused by other diseases or surgical operations&#xD;
&#xD;
          2. Those who have chronic gastrointestinal diseases such as Crohn's disease and&#xD;
             ulcerative colitis&#xD;
&#xD;
          3. Those who have recently used gastrointestinal motility drugs and within 5 times the&#xD;
             half-life&#xD;
&#xD;
          4. Those who are participating in other drug clinical trials&#xD;
&#xD;
          5. Refuse to participate in this study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jianbo Yu, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Tianjin Nankai Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yingya Cao, MD</last_name>
    <phone>15055324662</phone>
    <email>caoyingya1990@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Electroacupuncture Apparatus</name>
      <address>
        <city>Tianjin</city>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Yingya Cao, MD</last_name>
      <phone>15055324662</phone>
      <email>caoyingya1990@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Meng JB, Jiao YN, Zhang G, Xu XJ, Ji CL, Hu MH, Lai ZZ, Zhang M. Electroacupuncture Improves Intestinal Dysfunction in Septic Patients: A Randomised Controlled Trial. Biomed Res Int. 2018 Jun 26;2018:8293594. doi: 10.1155/2018/8293594. eCollection 2018.</citation>
    <PMID>30046610</PMID>
  </reference>
  <reference>
    <citation>Yoseph BP, Klingensmith NJ, Liang Z, Breed ER, Burd EM, Mittal R, Dominguez JA, Petrie B, Ford ML, Coopersmith CM. Mechanisms of Intestinal Barrier Dysfunction in Sepsis. Shock. 2016 Jul;46(1):52-9. doi: 10.1097/SHK.0000000000000565.</citation>
    <PMID>27299587</PMID>
  </reference>
  <reference>
    <citation>Li HF, Hu GQ, Liu WW. [Clinical trials of acupuncture of Jiaji (EX-B2) for treatment of gastrointestinal dysfunction in sepsis patients]. Zhen Ci Yan Jiu. 2019 Jan 25;44(1):43-6. doi: 10.13702/j.1000-0607.170579. Chinese.</citation>
    <PMID>30773861</PMID>
  </reference>
  <reference>
    <citation>Liu H, Zhu J, Ni HB, Hu XX. [Transcutaneous electrical acupoint stimulation for early enteral nutrition tolerance in patients with sepsis of gastrointestinal dysfunction: a multi-center randomized controlled trial]. Zhongguo Zhen Jiu. 2020 Mar 12;40(3):229-33. doi: 10.13703/j.0255-2930.20190426-0003. Chinese.</citation>
    <PMID>32270631</PMID>
  </reference>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 22, 2020</study_first_submitted>
  <study_first_submitted_qc>November 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 30, 2020</study_first_posted>
  <last_update_submitted>November 25, 2020</last_update_submitted>
  <last_update_submitted_qc>November 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Tianjin Nankai Hospital</investigator_affiliation>
    <investigator_full_name>Jianbo Yu</investigator_full_name>
    <investigator_title>Department of Anesthesiology, Director, Chief physician, Professor, Doctoral tutor</investigator_title>
  </responsible_party>
  <keyword>sepsis</keyword>
  <keyword>electroacupuncture</keyword>
  <keyword>intestinal dysfunction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

